Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine
- 1 January 1986
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 31 (1) , 69-72
- https://doi.org/10.1007/bf00870989
Abstract
The pharmacokinetics and metabolism of quinidine were investigated in extensive and poor metabolisers of sparteine. No differences in plasma clearance, terminal half life, volume of distribution or cumulative urinary excretion of quinidine, 3-hydroxyquinidine and quinidine-N-oxide were observed between phenotypes. Thus, it is unlikely that quinidine metabolism is controlled by the sparteine/debrisoquine gene locus.This publication has 11 references indexed in Scilit:
- Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidationJournal of Molecular Medicine, 1985
- Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralolEuropean Journal of Clinical Pharmacology, 1985
- Genetic polymorphism in drug oxidation: In vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1′-hydroxylase activitiesBiochemical Pharmacology, 1985
- A human cytochrome P-450 characterized by inhibition studies as the sparteine–debrisoquine monooxygenaseCanadian Journal of Physiology and Pharmacology, 1984
- Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsLife Sciences, 1983
- Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.British Journal of Clinical Pharmacology, 1982
- Specific determination of quinidine and metabolites in biological fluids by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entitiesClinical Pharmacology & Therapeutics, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Influence of the defective metabolism of sparteine on its pharmacokineticsEuropean Journal of Clinical Pharmacology, 1979